Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy
Context: Incidence, prevention, and management of complications of percutaneous nephrolitholapaxy (PNL) still lack consensus. Objective: To review the pidemiology of complications and their prevention and management. Evidence acquisition: A literature review was performed using the PubMed database...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
European urology
Year: 2012, Jahrgang: 61, Heft: 1, Pages: 146-158 |
| ISSN: | 1873-7560 |
| DOI: | 10.1016/j.eururo.2011.09.016 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.eururo.2011.09.016 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0302283811010232 
|
| Verfasserangaben: | Christian Seitz, Mahesh Desai, Axel Häcker, Oliver W. Hakenberg, Evangelos Liatsikos, Udo Nagele, David Tolley |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577238567 | ||
| 003 | DE-627 | ||
| 005 | 20220814182957.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180703s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eururo.2011.09.016 |2 doi | |
| 035 | |a (DE-627)1577238567 | ||
| 035 | |a (DE-576)507238567 | ||
| 035 | |a (DE-599)BSZ507238567 | ||
| 035 | |a (OCoLC)1341013232 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Seitz, Christian |d 1970- |e VerfasserIn |0 (DE-588)129401315 |0 (DE-627)394711335 |0 (DE-576)297641786 |4 aut | |
| 245 | 1 | 0 | |a Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy |c Christian Seitz, Mahesh Desai, Axel Häcker, Oliver W. Hakenberg, Evangelos Liatsikos, Udo Nagele, David Tolley |
| 264 | 1 | |c 2012 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online ahead of print on September 28, 2011 | ||
| 500 | |a Gesehen am 03.07.2018 | ||
| 520 | |a Context: Incidence, prevention, and management of complications of percutaneous nephrolitholapaxy (PNL) still lack consensus. Objective: To review the pidemiology of complications and their prevention and management. Evidence acquisition: A literature review was performed using the PubMed database between 2001 and May 1, 2011, restricted to human species, adults, and the English language. The Medline search used a strategy including medical subject headings (MeSH) and free-text protocols with the keywords percutaneous, nephrolithotomy, PCNL, PNL, urolithiasis, complications, and Clavien, and the MeSH terms nephrostomy, percutaneous/adverse effects, and intraoperative complications or postoperative complications. Evidence synthesis: Assessing the epidemiology of complications is difficult because definitions of complications and their management still lack consensus. For a reproducible quality assessment, data should be obtained in a standardized manner, allowing for comparison. An approach is the validated Dindo-modified Clavien system, which was originally reported by seven studies. No deviation from the normal postoperative course (Clavien 0) was observed in 76.7% of PNL procedures. Including deviations from the normal postoperative course without the need for pharmacologic treatment or interventions (Clavien 1) would add up to 88.1%. Clavien 2 complications including blood transfusion and parenteral nutrition occurred in 7%; Clavien 3 complications requiring intervention in 4.1.%; Clavien 4, life-threatening complications, in 0.6%; and Clavien 5, mortality, in 0.04%. High-quality data on complication management of rare but potentially debilitating complications are scarce and consist mainly of case reports. Conclusions: Complications after PNL can be kept to a minimum in experienced hands with the development of new techniques and improved technology. A modified procedure-specific Clavien classification should be established that would need to be validated in prospective trials. | ||
| 650 | 4 | |a Clavien | |
| 650 | 4 | |a Complication | |
| 650 | 4 | |a Incidence | |
| 650 | 4 | |a Management | |
| 650 | 4 | |a PCNL | |
| 650 | 4 | |a Percutaneous nephrolitholapaxy | |
| 650 | 4 | |a PNL | |
| 650 | 4 | |a Prevention | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Urolithiasis | |
| 700 | 1 | |a Häcker, Axel |d 1971- |e VerfasserIn |0 (DE-588)121732177 |0 (DE-627)705632865 |0 (DE-576)292855923 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European urology |d Amsterdam [u.a.] : Elsevier Science, 1976 |g 61(2012), 1, Seite 146-158 |h Online-Ressource |w (DE-627)300191596 |w (DE-600)1482253-2 |w (DE-576)099718103 |x 1873-7560 |7 nnas |a Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy |
| 773 | 1 | 8 | |g volume:61 |g year:2012 |g number:1 |g pages:146-158 |g extent:13 |a Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.eururo.2011.09.016 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0302283811010232 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180703 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 121732177 |a Häcker, Axel |m 121732177:Häcker, Axel |d 60000 |d 63100 |e 60000PH121732177 |e 63100PH121732177 |k 0/60000/ |k 1/60000/63100/ |p 3 | ||
| 999 | |a KXP-PPN1577238567 |e 3016045125 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Published online ahead of print on September 28, 2011","Gesehen am 03.07.2018"],"recId":"1577238567","language":["eng"],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Seitz, Christian","given":"Christian","family":"Seitz"},{"family":"Häcker","given":"Axel","display":"Häcker, Axel","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title_sort":"Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy","title":"Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy"}],"physDesc":[{"extent":"13 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Basel","dateIssuedDisp":"1976-","dateIssuedKey":"1976","publisher":"Elsevier Science ; Karger"}],"id":{"issn":["1873-7560","1421-993X"],"zdb":["1482253-2"],"eki":["300191596"]},"pubHistory":["Nachgewiesen 2.1976 -"],"part":{"issue":"1","pages":"146-158","year":"2012","extent":"13","volume":"61","text":"61(2012), 1, Seite 146-158"},"disp":"Incidence, prevention, and management of complications following percutaneous nephrolitholapaxyEuropean urology","note":["Ungezählte Beil. bis 40.2001: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"300191596","language":["eng"],"title":[{"title_sort":"European urology","subtitle":"official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology","title":"European urology"}]}],"name":{"displayForm":["Christian Seitz, Mahesh Desai, Axel Häcker, Oliver W. Hakenberg, Evangelos Liatsikos, Udo Nagele, David Tolley"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"id":{"eki":["1577238567"],"doi":["10.1016/j.eururo.2011.09.016"]}} | ||
| SRT | |a SEITZCHRISINCIDENCEP2012 | ||